Bollard Group’s Idexx Laboratories IDXX Stock Holding History

Bollard Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5	Closed	-$3K	–	523
2023 Q2	$3K	Buy	+5	New	+$2.4K	﹤0.01%	472

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Bollard Group's IDXX Position: Q3 2023 in Review

Bollard Group sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 5 shares — an estimated $3K sold.

Bollard Group first reported a position in IDXX in Q2 2023 and held it in 1 quarter. The position peaked at $3K in Q2 2023. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

Bollard Group reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
Bollard Group sold 5 Idexx Laboratories shares in Q3 2023, an estimated $3K.
Bollard Group first reported a position in Idexx Laboratories in Q2 2023 and held it in 1 quarter.
Bollard Group's Idexx Laboratories position peaked at $3K in Q2 2023.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.